Menu

Placental Health Influences Baby’s Future Schizophrenia Risk, Study Suggests

Complications during pregnancy may act via the placenta to magnify the effects of genetic risk factors.

May 29, 2018
Shawna Williams

ISTOCK, ILBUSCAComplications during pregnancy can magnify the effect of genetic risk factors for schizophrenia by altering gene expression in the placenta, a new study suggests. The paper appeared yesterday (May 28) in Nature Medicine.

“To me the key thing in this paper is the recognition that environmental factors in early development, prenatal factors, are likely to be very important in schizophrenia and just as important as genes,” Allan Brown of Columbia University Medical Center who was not involved in the study tells Scientific American.

An international team of researchers analyzed data from nearly 3,000 participants, including people with schizophrenia and healthy controls. The researchers found that, among people with known genetic risk factors, those who were products of a pregnancy complicated by conditions such as preeclampsia or diabetes were at least five times more likely to have the disease than were people born of uncomplicated pregnancies.

The researchers also analyzed gene expression in placental tissue from complicated and uncomplicated pregnancies. That assay revealed that genes associated with schizophrenia risk tended to be “turned on” in the placentas from complicated pregnancies, and that higher expression of those genes was associated with inflammation and other signs of stress in the tissue.

“We need to create a new risk score for schizophrenia, incorporating not only genes but also placental health,” study coauthor Daniel Weinberger of the Lieber Institute for Brain Research and the Johns Hopkins University School of Medicine tells STAT. “The odds of becoming schizophrenic based on your polygenic risk score is more than 10 times greater with these early-life complications than without them.”

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.
Corning Introduces New 1536-well Spheroid Microplate
Corning Introduces New 1536-well Spheroid Microplate
High-throughput spheroid microplate benefits cancer research, drug screening